Related by context. All words. (Click for frequent words.) 69 renal allograft 69 graft dysfunction 68 haematopoietic 67 transgene expression 67 clonogenic 67 prostate carcinoma 67 imatinib therapy 67 multivariate Cox 67 RRM1 66 SSc 66 colorectal carcinoma 66 lactate dehydrogenase 66 HER2 expression 66 liver histology 66 K ras mutations 65 clinicopathological features 65 multivariable analysis 65 prostate cancer CaP 65 lymph node metastasis 65 isoenzyme 65 allogeneic hematopoietic stem cell 65 renal fibrosis 65 syngeneic 65 alanine aminotransferase ALT 65 rs# [004] 65 pCR 65 Angiotensin converting enzyme 64 echocardiographic parameters 64 histological subtype 64 Leydig cell 64 PTPN# 64 preoperative PSA 64 androgen deprivation 64 peritoneal carcinomatosis 64 CR nPR 64 pretransplant 64 left ventricular systolic 64 metaplasia 64 Clusterin 64 multivariate analyzes 64 left ventricular diastolic 64 p# Shc 64 gastric carcinoma 64 thyroid peroxidase 64 univariate analysis 64 IPAH 64 microsatellite instability 64 hematological parameters 64 BEXXAR Therapeutic Regimen 64 ovarian carcinoma 64 CDKN2A 64 effector function 64 TIMP 1 63 clinicopathological 63 nephrogenic 63 thyrotropin 63 hematopoietic cell 63 methylenetetrahydrofolate reductase 63 bFGF 63 hepatorenal syndrome 63 multivariable Cox 63 thyroglobulin 63 granulocyte 63 ABCB1 63 BMPR2 63 obstructive coronary artery 63 PSA nadir 63 pelvic lymphadenectomy 63 apolipoprotein E4 63 mutated K ras 63 posttransplant 63 intact parathyroid hormone 63 MLH1 63 p# activation 63 CYP#D# genotype 63 gastric carcinogenesis 63 pancreatic adenocarcinoma 63 perioperative complications 63 chemosensitivity 63 SNP rs# [002] 63 allogeneic SCT 63 mRNA expression 63 tyrosine phosphorylation 63 β cell 63 VEGF expression 63 univariate 63 elevated ALT 62 IL 1ß 62 metachronous 62 neurocognitive function 62 Haptoglobin 62 pDC 62 intraobserver 62 abnormal p# 62 interferon γ 62 SGPT 62 LRP5 62 #q# deletion syndrome 62 sleeve lobectomy 62 Endothelial dysfunction 62 NKT cell 62 liver metastasis 62 FLT3 62 tumorigenicity 62 HER2 overexpression 62 prognostic indicator 62 stage IIIb IV 62 baseline LDH 62 protein tyrosine phosphatase 62 cTnI 62 symptomatic VTE 62 VKORC1 62 NR#A# 62 antibody mediated 62 5 HTTLPR 62 differential gene expression 62 AST ALT 62 apolipoprotein B 62 plasma leptin 62 histologic subtype 62 axillary node 62 cisplatin resistant 62 gene polymorphism 62 urothelial carcinoma 62 pT3 62 plasma creatinine 62 carcinoembryonic antigen 62 nonischemic 62 nucleoside naive patients 62 RAS RAF MEK 62 atherosclerotic lesions 62 monocyte chemoattractant protein 62 extracapsular extension 62 HbF 62 colorectal adenoma 62 Non inferiority 62 serum HBV DNA 62 oncologic outcomes 62 cardiac perfusion 62 nodal metastasis 62 Fas ligand 62 clinically localized prostate 62 HSCT 62 Dysregulation 62 ADAMTS# 62 graft occlusion 62 immunohistochemical staining 62 LPS induced 62 lupus anticoagulant 62 acute humoral rejection 62 intravesical therapy 62 leukocyte count 62 antibody titer 62 morphometric vertebral fractures 62 CsA 62 aspartate aminotransferase AST 62 hemoglobin Hb 62 hepatic lipase 62 cystatin 62 immunostaining 62 HuR 62 hematopoietic cancers 62 pro angiogenic 62 #ß 62 Subgroup analysis 61 multivariate logistic regression 61 serum estradiol 61 lymphocytosis 61 squamous intraepithelial lesions 61 pancreatic endocrine 61 TNFalpha 61 euthymic patients 61 MSH2 61 platelet reactivity 61 variant allele 61 STRIDE PD 61 APOL1 61 glomerular filtration rate 61 renal tumors 61 coexpression 61 sFlt 1 61 relapsed MM 61 SERCA2a 61 cystatin C 61 FGF2 61 GABAergic interneurons 61 CTAP# Capsules 61 carotid IMT 61 macroalbuminuria 61 allogeneic transplant 61 allogeneic bone marrow 61 nodal metastases 61 hepatocellular carcinomas 61 homozygotes 61 genotypic resistance 61 beta adrenergic receptor 61 intima media thickness 61 biochemical recurrence 61 transplantation HCT 61 GH deficiency 61 activin 61 cardiac dysfunction 61 factor PlGF 61 ERK1 2 61 apolipoproteins 61 Nilotinib 61 mTOR signaling 61 bladder carcinoma 61 IFN ß 61 catechol O methyltransferase 61 castrate resistant 61 myeloablative 61 ADPKD 61 mediated inhibition 61 coronary stenosis 61 ERCC1 61 urine cytology 61 D dimer 61 5alpha reductase 61 renal tubular 61 cardiac allograft vasculopathy 61 glycated hemoglobin levels 61 postoperative chemotherapy 61 lymphangiogenesis 61 osteoblast 61 liver transplant recipients 61 nitrotyrosine 61 OPCAB 61 metastatic malignant 61 Treg cell 61 CD8 + 61 radical prostatectomy RP 61 serum lipid levels 61 hypothalamic pituitary 61 immunomodulation 61 lung metastasis 61 grade cervical intraepithelial 61 glutamic acid decarboxylase 61 postoperative pulmonary 61 ERBB2 61 metabolomic profiles 61 pT2 61 SCr 61 autoregulation 61 thrombocytopenic 61 lesional 61 radical cystectomy 61 PDGFR 61 GSTP1 61 HIV HCV coinfected 61 GRNCM1 61 metastatic neuroendocrine tumors 61 CIN2 + 61 pancreatic islet 61 Histologic 61 IL#B 61 epithelial tumors 61 HLA matched 61 medically inoperable 61 intratumoral 61 hepatoma 61 cytoreductive nephrectomy 61 adenoma recurrence 61 IFN γ 61 hepatic fibrosis 61 bronchopulmonary dysplasia BPD 61 riociguat 61 allogeneic stem cell 61 allogeneic HSCT 61 nonalcoholic steatohepatitis 61 BCR ABL mutations 61 Index CDAI 61 myeloperoxidase 61 PCWP 61 affective psychosis 61 STAT3 activation 61 fulminant hepatic failure 61 Apolipoprotein E 61 immunohistochemical 61 AGTR1 61 TMEM#B 61 normal karyotype 61 isoprostane 61 adipogenic 61 estimated glomerular filtration 60 alanine aminotransferase 60 monocytic 60 Garcia Manero 60 iPTH 60 TIMP 60 colorectal tumor 60 natriuretic peptide 60 apolipoprotein A1 60 lactate dehydrogenase LDH 60 onset diabetes mellitus 60 HLA DR4 60 aneuploidy 60 Radical prostatectomy 60 Ki# 60 Cytogenetic 60 hypoperfusion 60 prefrontal cortical 60 TRAIL induced apoptosis 60 F FDG PET 60 neoplastic 60 glial derived neurotrophic 60 T2D 60 serum phosphate 60 hyperphenylalaninemia HPA due 60 mg BID dose 60 mTOR mammalian target 60 HBeAg 60 logistic regression analysis 60 PDGF receptor 60 inducible nitric oxide synthase 60 bioavailable testosterone 60 LV dysfunction 60 CD# + [001] 60 neurite outgrowth 60 Kaplan Meier analysis 60 serum ALT 60 E selectin 60 chronic myocardial ischemia 60 gastric adenocarcinoma 60 proto oncogene 60 diabetes mellitus DM 60 allogenic 60 leukemic cell 60 polycythemia vera essential thrombocythemia 60 plasma pharmacokinetics 60 sarcomatoid 60 Macrophage 60 KRAS oncogene 60 dopamine D2 receptor 60 constitutively expressed 60 p#NTR 60 immunopathology 60 Doxil ® 60 operable breast cancer 60 serum biomarker 60 PON1 60 engraftment 60 fibrinolysis 60 preserved ejection fraction 60 eNOS 60 histone acetylation 60 renal cell carcinomas 60 PCa 60 selective inhibition 60 serum TSH 60 HepG2 cells 60 proinflammatory cytokine 60 esophageal carcinoma 60 papillary RCC 60 posttranslational modification 60 mucinous 60 gefitinib Iressa 60 NOD mouse 60 UGT#A# * 60 lymphadenectomy 60 LV hypertrophy 60 leukemia AML 60 PIGF 60 synthase TS 60 ara C 60 R0 resection 60 psychiatric comorbidity 60 TAXUS Express Stent 60 interleukin IL -# 60 pre eclamptic 60 bronchopulmonary dysplasia 60 biopsied breast 60 heparanase 60 CYP#A# CYP#D# 60 euthyroid 60 p# biomarker 60 PSADT 60 hsCRP levels 60 COX2 60 prospectively defined 60 hepatocellular 60 stem cell engraftment 60 pathophysiological effects 60 radiochemotherapy 60 TACE 60 p#INK#a 60 Allogeneic 60 collagen degradation 60 serum calcium levels 60 T2DM 60 immunoreactivity 60 inotropic 60 kidney urologic 60 IFN beta 60 immunosuppression therapy 60 human leukocyte antigens 60 aspartate aminotransferase 60 AT1R 60 serum lipid 60 β catenin 60 MTT assay 60 HNSCC 60 APOE e4 60 cranial irradiation 60 T1c 60 Prognostic factors 60 HRCT 60 p# mutation 60 CYP#C# [002] 60 plasma lipid 60 cytoreduction 60 % CI #.#-#.# [005] 60 PECAM 1 60 rs# [002] 60 Lymph node 60 atherosclerotic lesion 60 complete cytogenetic response 60 univariate analyzes 60 mIU L 60 antigen PSA 60 locoregional 60 HER2 positive cancers 60 upregulates 60 p# antigen 60 Prognostic significance 60 MGMT gene 60 TNF α 60 HBeAg seroconversion 60 steroidogenic 60 SUVmax 60 beta1 integrin 60 serum urate levels 60 albumin excretion 60 immunocompetent 60 glomerular filtration 60 de novo AML 60 biochemical relapse 60 hematologic toxicity 60 cell adhesion molecule 60 multiple logistic regression 60 steroidogenesis 60 peripheral blood mononuclear 60 urothelial 60 ENPP1 60 hormone receptor status 60 HBeAg negative 60 CEACAM1 60 immunosuppressive regimen 60 CC genotype 60 MELD scores 60 tumoral 60 promoter polymorphism 60 inhibin 60 cardiac troponin 60 EpCAM expression 60 paricalcitol 60 CD# upregulation 60 Bonferroni correction 60 mRCC 60 SFRP1 60 splenocytes 60 shorter telomere length 60 unfavorable cytogenetics 60 cellularity 60 penetrance 60 perioperative mortality 60 debulking surgery 60 antitumor efficacy 60 cytoreductive surgery 60 chemoresistant 60 soluble CD# ligand 60 vaso occlusive crisis 60 Annexin V 60 preserved LVEF 60 chemoresistance 60 T1DM 60 arterial thickening 60 locoregional recurrence 60 carotid artery stenting CAS 60 congenital toxoplasmosis 60 cystectomy 60 trophoblast cells 60 radical nephrectomy 60 endocrine therapies 60 upregulating 60 TOP2A 60 HLA DR 60 mutant p# 60 Lymphocytic 60 NMIBC 60 LVNC 59 NYHA functional class 59 μmol L 59 NPM1 mutation 59 distant metastasis 59 HOMA IR 59 HGPIN 59 ABL1 59 intraventricular hemorrhage 59 microvessel density 59 astrocytomas 59 mutated KRAS 59 CYP# [002] 59 acinar 59 IDH mutations 59 advanced adenoma 59 childhood acute lymphoblastic 59 ^ sup #m 59 TGFß 59 promoter methylation 59 lymph node dissection 59 cytomegalovirus infection 59 Multivariate analysis 59 interobserver reliability 59 extracellular dopamine 59 LHRH receptor positive 59 gonadotropins 59 interleukin IL 59 International Prognostic Scoring 59 thyrotropin levels 59 ADAS Cog 59 myofibroblast 59 HIF 1alpha 59 extramedullary 59 coagulation abnormalities 59 heterozygotes 59 radiosensitivity 59 plasma folate 59 gene polymorphisms 59 micrometastasis 59 hemodynamically significant 59 breast cancer subtypes 59 NOD SCID mice 59 % CI #.#-#.# [007] 59 monogenic 59 PON1 gene 59 nondiabetic patients 59 transplantation HSCT 59 glycosylated hemoglobin levels 59 apo B 59 ImmuKnow 59 glucose homeostasis 59 adrenocortical 59 GSTT1 59 Upregulation 59 cerebral perfusion 59 haematopoietic stem cell 59 neointimal hyperplasia 59 leukocytosis 59 CALGB 59 EGFR HER2 59 coagulopathy 59 KIF6 gene 59 Lp PLA 2 59 calculated creatinine clearance 59 microdeletion 59 intracranial stenosis 59 primary hyperparathyroidism 59 BRAF V#E 59 Leukemias 59 μg ml 59 allelic 59 resected pancreatic cancer 59 interleukin IL -6 59 specific antigen PSA 59 serum triglycerides 59 corrected QT interval 59 embryoid body 59 Kaplan Meier curve 59 hepatic arterial 59 airway responsiveness 59 vWF 59 TMPRSS2 ERG 59 myocardial reperfusion 59 neovascularisation 59 Prostate specific antigen 59 Gleevec resistant 59 androgen independent 59 lung adenocarcinomas 59 TGF ß1 59 colorectal adenocarcinoma 59 pg ml 59 serum phosphorous 59 hepatectomy 59 everolimus eluting stents 59 podocyte 59 adrenalectomy 59 dimeglumine 59 Helicobacter infection 59 Immunohistochemical analysis 59 uPA 59 Leydig cells 59 CYP #D# 59 inhibin B 59 motor neuron degeneration 59 CD# expression [002] 59 CDH1 59 somatic mutation 59 p tau 59 Solid Tumors criteria 59 LNCaP cells 59 neoadjuvant chemotherapy 59 serum parathyroid hormone 59 flavopiridol 59 WT1 59 airway hyperresponsiveness 59 intravascular hemolysis 59 cyclin E 59 H#K#me# 59 steroid refractory 59 atherothrombotic disease 59 prognostic indicators 59 squamous histology 59 ERK signaling 59 electrophysiologic 59 vasopressor 59 MMSE score 59 orthotopic 59 sunitinib Sutent 59 HDAC6 59 TNFa 59 retransplantation 59 CCR5 delta# 59 β1 59 gestational hypertension 59 postoperative complication 59 protein tyrosine kinase 59 P cadherin 59 sarcosine 59 S#A# [002] 59 colony stimulating factor 59 System IPSS 59 sensitivity specificity 59 thromboembolic complications 59 nonmetastatic 59 RQ PCR 59 hypothalamus pituitary 59 pmol L 59 ERK activation 59 androgen receptor AR 59 tumor necrosis 59 deacetylation 59 intestinal mucosal 59 CYP#B# 59 gastric cardia 59 rs# [001] 59 BCL#A 59 unresectable tumors 59 hepatocyte 59 chromosomal rearrangement 59 HCT# 59 progesterone receptor PR 59 Kinoid 59 TP# mutations 59 neuropathological 59 FGFR3 59 preoperative chemotherapy 59 HIF 1a 59 immunosuppressive regimens 59 hematopoietic cells 59 prognostic significance 59 neuromotor 59 virologic responses 59 lymphocytic 59 F FDG uptake 59 TNF blocker therapy 59 EGFR receptor 59 postoperative mortality 59 cirrhotic patients 59 histopathological 59 TGFβ 59 bronchoalveolar lavage 59 stratifying patients 59 lipid elevations 59 intracoronary 59 chronic eosinophilic leukemia 59 epithelial ovarian cancer 59 phenotypic expression 59 antiangiogenic agent 59 hip resurfacing arthroplasty 59 Rab5 59 renal scarring 59 Lung transplantation 59 GISTs 59 receptor kinase 59 mucosal healing 59 cardiovascular hospitalizations 59 NKG2D 59 antiphospholipid syndrome 59 lymphovascular invasion 59 pDCs 59 Interferon gamma 59 p#HER# 59 nonnucleoside reverse transcriptase inhibitors 59 CMV reactivation 59 platelet activation 59 KRAS mutations 59 antiretroviral naïve 59 behavioral disinhibition 59 Genotypic 59 etiologic 59 Univariate analysis 59 acute GvHD 59 PDGFR alpha 59 erythropoietic 59 lumbar spine BMD 59 autologous transplants 59 decitabine 59 karyotypes 59 sCD# 59 neuritic 59 MTHFR 59 IFN α 59 retinol binding protein 59 myeloproliferative neoplasms 59 renal transplantation 59 Cytochrome P# 59 neovascular 59 familial aggregation 59 ALI ARDS 59 CD4 + CD8 + 59 postintervention 59 Tie2 59 HER2 HER2 59 E#F# 59 azacitidine 59 seminal vesicle invasion 59 dysbindin 59 CTEPH 59 downregulation 59 HAQ DI 59 lymphoid cells 59 primary percutaneous coronary 59 Inhaled nitric oxide 59 wildtype 59 nonalcoholic steatohepatitis NASH 59 pancreatic carcinoma 59 recurrent VTE 59 C#Y 59 biopsy Gleason 59 estrogen receptor ER 59 circulating endothelial cells 59 serum IGF 59 gene loci 59 Hypoxia Inducible Factor 59 anemia hemoglobin 59 PDGF B 59 dopaminergic neuron 59 lamivudine resistant 59 C#T [002] 59 fibrin deposition 59 oblimersen 59 weekly subcutaneous injections 59 microsomal 58 pulmonary exacerbations 58 percutaneous vertebroplasty 58 skeletal metastases 58 serum PSA 58 proband 58 Immunohistochemical staining 58 Endometrial 58 BCL2 58 arteriolar 58 miR #a [001] 58 testicular germ cell 58 COL#A# 58 allele frequencies 58 natriuretic peptides 58 endoglin 58 seropositive patients 58 Cystatin C 58 TYMS 58 intraventricular 58 DNA methylation patterns 58 erlotinib Tarceva ® 58 anthracycline induced 58 sargramostim 58 RIP1 58 postoperative morbidity 58 perioperative morbidity 58 nephrectomy 58 IgG4 58 humoral immunity 58 Hypothalamic 58 histologies 58 pulmonary artery banding 58 unfractionated heparin UFH 58 selective modulator 58 alkaline phosphatase ALP 58 Atypical Hemolytic Uremic Syndrome 58 CHD7 58 FDG PET imaging 58 transgenic mice expressing 58 anti Mullerian hormone 58 prostatic tissue 58 glial tumors 58 vWD 58 mesangial 58 pheochromocytoma 58 ERalpha 58 Protein Kinase C 58 myocardial viability 58 epithelia 58 Cancer Epidemiol Biomarkers Prev 58 Hematologic 58 transfusion syndrome 58 mRNA encoding 58 neuronal differentiation 58 Akt activation 58 antioxidant supplementation 58 lipoprotein levels 58 umbilical vein 58 Am J Cardiol 58 triiodothyronine 58 epididymal 58 PROSTVAC VF 58 bronchoalveolar lavage fluid 58 lipoprotein Lp 58 grade squamous intraepithelial 58 HLA DRB1 * 58 gemcitabine Gemzar 58 proapoptotic 58 troponin T 58 urine albumin 58 p = .# [002] 58 autonomic dysfunction 58 CagA 58 Raf MEK ERK 58 leiomyomas 58 Overexpression 58 persistent pulmonary hypertension 58 myocardial function 58 definite stent thrombosis 58 Osteopontin 58 Microarray analysis 58 prognostic markers 58 completely resected 58 FUSILEV enhances 58 immune reconstitution 58 distant metastases 58 SOD2 58 FGFR1 58 MGd 58 ELBW infants 58 T1a 58 postoperative AF 58 histologic 58 N. gonorrhoeae 58 hormone receptor negative 58 invasive ductal 58 Flu Cy 58 p = #.# [003] 58 dose Iluvien 58 hepatic cirrhosis 58 c MYC 58 chemoembolization 58 lymphocyte counts 58 HIV coinfected 58 response CCyR 58 Symadex 58 TMPRSS2 ERG fusion 58 hypogonadal 58 MACCE 58 Ebstein anomaly 58 Accelerated Partial Breast Irradiation 58 OnDose TM 58 Western blotting 58 repolarization 58 Polymorphisms 58 prognostic biomarker 58 quantitative reverse transcriptase 58 independent prognostic marker 58 CD# CD# 58 EGFR TKIs 58 constitutively active 58 noncardiac 58 caveolin 1 58 atypical hyperplasia 58 monozygotic twins 58 PTEN protein 58 CYT# potent vascular disrupting 58 bivariate 58 eGFR 58 antiangiogenic activity 58 fibrosis scarring 58 thrombophilia 58 receptor tyrosine kinase inhibitor 58 c myc gene 58 neoplastic transformation 58 serum PTH 58 intracranial hemorrhage ICH 58 IDH1 mutation 58 TGF alpha 58 MetS 58 tumor infiltrating lymphocytes 58 rFSH 58 esophageal squamous cell carcinoma 58 oncogenesis 58 autologous transplantation 58 siRNA conjugates 58 PLX STROKE targeting 58 myelodysplastic myeloproliferative diseases 58 Hp2 2 58 hMG 58 CIN3 58 #ng/ml 58 mol L 58 succinate dehydrogenase 58 ependymoma 58 aortic atherosclerosis 58 Operative mortality 58 virologic response 58 glomerular 58 LV ejection fraction 58 Chronic pancreatitis 58 beta blocker therapy 58 nephron 58 hyperprolactinemia 58 melatonin receptor 58 allogeneic hematopoietic cell 58 autoantibody levels 58 abdominal adiposity 58 microglial 58 systolic dysfunction 58 colon carcinoma 58 PITX2 methylation 58 prostate adenocarcinoma 58 elevated serum creatinine 58 triacylglycerol 58 Cathepsin B 58 Insulin sensitivity 58 Estrogen Receptor 58 nonobese 58 functional polymorphism 58 HbA 1c levels 58 Hazard Ratio 58 haematologic 58 PC# cells 58 serum prostate 58 thiopurine 58 maternal serum 58 hematopoietic progenitor cells 58 breast carcinomas 58 PBMCs 58 cytologic 58 serum BDNF 58 aminotransferase levels 58 kinase inhibition 58 artery stenosis 58 virological response 58 predictive biomarker 58 nephron sparing surgery 58 Prognostic 58 preintervention 58 adjuvant tamoxifen 58 lung fibrosis 58 nmol liter 58 baroreflex 58 MMP# 58 transmembrane protein 58 hepatic insulin sensitivity 58 hypermethylated 58 choroidal neovascularization 58 #T# L1 58 mixed hyperlipidemia 58 recurrent glioblastoma multiforme 58 FKBP# 58 follicular lymphoma FL 58 residual confounding 58 advanced neoplasia 58 aplastic anemia AA 58 tissue oxygenation 58 serum concentrations 58 TOP2A gene 58 breast carcinoma 58 myeloid 58 p = NS 58 VMAT2 58 hENT1 58 PNH patients 58 Pseudomonas aeruginosa infections 58 Elevated serum 58 pertussis toxin 58 recurrent venous thromboembolism 58 subclinical hypothyroidism 58 TGF β 58 MYH9 gene 58 multivariable logistic regression 58 ptau 58 malignant prostate 58 miRview mets 58 nonfasting triglycerides 58 adrenocortical cancer 58 serum creatinine levels 58 FDG uptake 58 pneumonectomy 58 Adiposity 58 induced apoptosis 58 serum albumin